Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC), a main subtype of lung cancer, is one of the most common causes of cancer death in men and women worldwide. Circulating tumor DNA (ctDNA), tyrosine kinase inhibitors (TKIs) and immunotherapy have revolutionized both our understanding of NSCLC, from its diagnosis t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Chennianci, Zhuang, Weihao, Chen, Limin, Yang, Wenyu, Ou, Wen-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082279/
https://www.ncbi.nlm.nih.gov/pubmed/32206559
http://dx.doi.org/10.21037/tlcr.2020.01.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082279/
https://www.ncbi.nlm.nih.gov/pubmed/32206559
http://dx.doi.org/10.21037/tlcr.2020.01.09

Ejemplares similares